LANCE ROBBINS: Open Payments
NPI 1578863791 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 70 payments from 12 companies in 2025. Trend: 2023 $720 · 2024 $661 · 2025 $2,653
Food & beverage: $1,986Travel & lodging: $664Education: $3
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $1,131 |
| PFIZER INC. | 13 | $320 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $288 |
| E.R. Squibb & Sons, L.L.C. | 7 | $238 |
| Novartis Pharmaceuticals Corporation | 16 | $228 |
| Edwards Lifesciences Corporation | 2 | $202 |
| Amgen Inc. | 9 | $140 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Davol Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: WATCHMAN, LifeVest, LEQVIO, CAMZYOS, VYNDAQEL, PASCAL, ELIQUIS, REPATHA.
Industry payments across FL — which companies pay providers there.
